ARKAITZ
CARRACEDO PEREZ
INVESTIGADOR/A DISTINGUIDO/A
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Clínico San Carlos de Madrid (3)
2022
-
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
Journal of Clinical Investigation, Vol. 132, Núm. 7
2011
-
Stimulation of ALK by the growth factor midkine renders glioma cells resistant to autophagy-mediated cell death
Autophagy, Vol. 7, Núm. 9, pp. 1071-1073
-
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action
Cell Death and Differentiation, Vol. 18, Núm. 6, pp. 959-973